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IllustratIve case 
A	healthy	60-year-old	Chicago	woman	
who	takes	1500	mg	calcium	and	a	multi	
vitamin	daily	tells	you	she	has	read	that	
extra	vitamins	prevent	cancer.	She	is	par-
ticularly	concerned	about	cancer	because	
of	her	strong	family	history.	Should	you	
recommend	that	she	take	any	additional	
vitamins	to	reduce	her	risk	of	cancer?
background
z  Will this trial pass the  
test of time? We think so
Wouldn’t it be nice if we could recom-
mend something as simple and safe as a 
daily vitamin to reduce the risk of cancer? 
Until now, we have had no definitive evi-
dence to support such a recommendation. 
The Lappe et al trial, however, concluded 
that improving calcium and vitamin D 
nutritional status substantially reduces 
all-cancer risk in postmenopausal wom-
en.1 Will this single, relatively small study 
pass the test of time and be confirmed by 
future clinical trials? We think so. 
• The estimated relative risk reduction 
was dramatic (0.232) and the 95% confi-
dence interval was 0.09 to 0.60, meaning 
that the true relative risk reduction has a 
95% probability of being in the range of 
40% to 91%. The P value of <.005 sug-
gests that the probability of this finding 
occurring by chance alone is less than 1 
in 200. 
• Our critical appraisal found no 
significant flaws in this randomized con-
trolled trial.
• Vitamin D is known to have cancer 
protective effects at the cellular level.
• Prior population based studies sup-
port the association between vitamin D 
and cancer prevention.
For these reasons—and the fact that 
1000 IU vitamin D is very safe for most 
patients—we find this single RCT convinc-
ing as a practice changer. For us, the poten-
tial benefit outweighs the potential harm.
united states Preventive services task 
Force. A 2003 report on “routine vitamin 
supplementation to prevent cancer and 
cardiovascular disease” cited insufficient 
evidence to recommend the use of supple-
mental vitamins A, C, E, multivitamins 
with folic acid, or antioxidants to prevent 
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Potential benefit 
outweighs  
potential harm
Increasing	the	dose	of	vitamin	
D3	from	the	current	standard	
of	400–600	IU	per	day	to	
1000	IU	per	day	lowers	future	
risk	of	cancer	in	women	
older	than	age	55	who	do	
not	get	adequate	vitamin	D	
from	sun	exposure	or	diet.1
Strength	of	recommendation	(Sor)	
a:		Well	done	randomized	controlled	trial2
lappe	Jm,	Travers-Gustafson	D,	Davies	Km	et	
al.		vitamin	D	supplementation	reduces	cancer	
risk:	results	of	a	randomized	trial.		Am J Clin Nutr	
2007;	85:1586–1591.
Practice changer 
PURLs methodology
The criteria and findings  
leading to the selection of this 
study as a Priority Update  
from the Research Literature 
can be accessed at  
www.jfponline.com/purls.
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cancer or cardiovascular disease; vitamin 
D is not mentioned.3
Institute of medicine. In 2005, the 
IOM suggested an Adequate Intake (AI) 
of vitamin D of 400 IU for women from 
51 to 70 years of age, and 600 IU for 
women over 70 years of age, to maintain 
bone health and normal calcium metabo-
lism in healthy women. The IOM cited 
epidemiologic studies showing an inverse 
association between either increased sun 
exposure or higher vitamin D levels and 
decreased risk of cancer, and included the 
caveat that it was premature to recom-
mend taking vitamin D for cancer preven-
tion until well-designed trials prove that 
vitamin D is protective against cancer.4 
electronic knowledge resources that 
are evidence-based and frequently up-
dated did not recommend vitamin D 
for cancer prevention on the dates we 
searched.5–8
clInIcal context
z  Food, sun, supplements 
may not deter deficiency 
Few people get enough vitamin D to match 
the dosage that reduced cancer incidence 
in this trial. In fact, inadequate vitamin D 
intake, even to meet current standards, 
is surprisingly common—even in people 
who are apparently conscious of their nu-
tritional needs. A Boston hospital found 
that 32% of healthy students, physicians, 
and resident physicians were vitamin-D 
deficient, despite drinking a glass of milk 
daily, taking a daily multivitamin, and eat-
ing salmon at least once a week.9 An es-
timated 1 billion people worldwide have 
vitamin D deficiency or insufficiency.9
Many factors affect vitamin D levels 
(TABLE).9 Foods that contain vitamin D3 
include fortified milk (100 IU per cup) 
and oily fish, including salmon, tuna, sar-
dines, mackerel, and herring (200–300 
IU per 3.5-oz serving). Sun exposure for 
10 to 15 minutes (without sunscreen) 
at least twice a week to the face, arms, 
hands, or back is considered sufficient to 
provide adequate vitamin D during sum-
mer or in warm climates.
Many patients need supplements 
to reach the levels provided by 1000 IU 
daily, especially in colder climates. Most 
over-the-counter supplements containing 
vitamin D alone contain 400 to 1000 IU 
vitamin D3. Prescription vitamin D2 cap-
sules contain 50,000 IU.9 Vitamin D is 
available as vitamin D2 and D3: 
•  vitamin d2 is usually labeled vitamin D 
or calciferol. Vitamin D2 is only 30% as 
effective as vitamin D3 (doses should be 
adjusted accordingly). 
•  vitamin d3 is labeled vitamin D3 or 
cholecalciferol.
study summary 
z  Cancer was  
a secondary outcome
This trial was well designed and execut-
ed, with impressive findings. The primary 
outcomes were related to skeletal status 
3 ways to get vitamin D: Food, sun, and supplements9 
 source amount 
Food 1	cup	of	fortified	milk		 100	IU	vitamin	D3
	 one	serving	(3.5	oz)	of	oily	fish	(salmon,		 200	to	300	IU	vitamin	D	
	 tuna,	sardines,	mackerel	or	herring)	
sun (ultraviolet  expose	face,	arms,	hands,	or	back	for	 3000	IU	vitamin	D3 
b radiation) 10	to	15	minutes	(without	sunscreen)		 per	exposure	
	 at	least	twice	a	week	during	summer		
	 months	or	in	warm	climates		
supplements vitamin	D3		 1000	IU/day
	 vitamin	D2	 50,000	IU	every	2	to	4	weeks
tABLE
Improving  
vitamin D  
nutritional status 
substantially  
reduces the  
all-cancer risk in 
post-menopausal 
women
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Vitamin D lowers cancer risk
and calcium economy. Cancer incidence 
was one of the secondary outcomes. 
This population-based study was ran-
domized, double-blinded, and placebo-
controlled, with concealed allocation. The 
researchers enrolled 1180 women older 
than 55 years of age, with no known can-
cer, and with adequate mental and physi-
cal health to allow an expected 4 years 
of participation in the trial. The trial was 
conducted in rural Nebraska. Eighty-six 
percent of the participants completed the 
study. Participants were randomly as-
signed to 3 groups: 
• Placebo (calcium placebo plus vita-
min D placebo, n=266)
• calcium-only (1400 mg calcium ci-
trate or 1500 mg calcium carbonate plus 
vitamin D placebo, n=416) 
• calcium + d (1000 IU [25 mcg] vita-
min D plus calcium [as above], n=403) 
Every 6 months, adherence was as-
sessed by bottle weight. Mean adherence 
(taking ≥80% of assigned doses) was 
85.7% for vitamin D and 74.4% for cal-
cium. Serum samples were analyzed for 
25(OH)D at baseline and then yearly.1
Key results
Fifty women developed non-skin cancer 
during the study: 13 in the first year, and 
37 during the second to fourth years. 
Excluding cancer diagnosed in the first 
year (it was assumed that these cancers 
were present, though undiagnosed, at 
entry), the relative risk reduction (RRR) 
for the calcium + D group was 0.232 
(confidence interval [CI], 0.09–0.60; 
P<.005), and the RRR for the calcium-
only group was 0.587 (95% CI, 0.29–
1.21; P=.147) compared with the pla-
cebo group. 
number needed to treat (NNT) to 
prevent 1 case of cancer for the calcium 
+ D group is 21, with an absolute risk re-
duction of 0.048, or approximately 5%.
risk reduction. Using baseline 
25(OH)D concentration as the predic-
tor variable and cancer as the outcome 
variable in logistic regression, Lappe et al 
predicted a 35% reduced cancer risk for 
every 25 nmol/L (10 ng/mL) increase in 
serum 25(OH)D.1
What’s neW?
z  First RCT to show 
reduced cancer incidence
This is the first randomized-controlled 
clinical trial to show that vitamin D re-
duces cancer risk. (It is important to note 
that one prior randomized controlled tri-
al10 found no impact on cancer incidence; 
however, that trial used a vitamin D3 dose 
of 400 IU, which is lower than the 1000 
IU dose used by Lappe et al.) 
vitamin d curbs carcinogenic potential. 
The new findings build on prior basic re-
search, which established the pathophysi-
ologic process by which vitamin D may 
prevent cancer in humans. Vitamin D 
receptors are found not only in the small 
intestines, bones, and kidneys, but also in 
most other tissues, including skin, colon, 
prostate, breast, and brain. The interaction 
of 1,25(OH)2D with vitamin D receptors 
induces terminal differentiation and apop-
tosis and inhibits cellular growth, angio-
genesis, and metastatic potential.10 
other studies suggest vitamin d plays 
a part. Previous population-based studies 
also suggested an association between vi-
tamin D and reduced cancer incidence. 
Lin et al, as part of the Women’s 
Health Study, found that higher intake 
of calcium and vitamin D was associated 
with a lower risk of breast cancer in pre-
menopausal but not in postmenopausal 
women. The highest dosage quintile was 
>548 IU; therefore, many if not most 
women likely ingested an inadequate dose 
of vitamin D to reduce risk of cancer.11
The Health Professionals Follow-up 
Study, which followed a cohort of 47,800 
men, from 1986 until 2000, found that 
low levels of vitamin D were associated 
with increased incidence of cancer and 
mortality.12
In the only other randomized con-
trolled trial of vitamin D and cancer 
(also part of the Women’s Health Initia-
tive), Wactawski-Wende et al found no 
To implement  
all USPSTF- 
recommended 
preventive health 
services would 
take 7.4 hours  
per day
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difference in the risk of colorectal can-
cer between women taking calcium and 
vitamin D and women taking placebo, 
over an average of 7 years of follow-up. 
However, the vitamin D dose was only 
400 IU daily, the dosage recommended 
for general health and bone health.13
caveats
z Consider toxicity unlikely
Although excess vitamin D intake, lead-
ing to a serum level of 25-hydroxyvi-
tamin D (25[OH]D) >150 ng/mL, can 
cause toxicity, the IOM has set the toler-
able upper intake level of vitamin D (a 
fat-soluble vitamin stored in the liver) at 
2000 IU (50 mcg) for adults and children 
older than 1 year. Moreover, studies have 
shown that adults can tolerate doses as 
high as 10,000 IU per day.4
symptoms of toxicity include nausea, 
vomiting, poor appetite, constipation, 
weakness, and weight loss as well as signs 
and symptoms of hypercalcemia, includ-
ing mental status changes, renal failure, 
and arrhythmias.4 
diseases and drugs that affect serum 
levels. Patients with mild to moderate re-
nal failure or chronic granulomatous dis-
eases, such as sarcoidosis, are at higher 
risk of developing vitamin D toxicity. 
Patients with malabsorption syndromes, 
mild or moderate hepatic failure, or who 
take certain medications, like anticon-
vulsants or glucocorticoids, that increase 
vitamin D metabolism may need higher 
doses of vitamin D.9
the good sun. Exposure to sunlight 
never leads to vitamin D toxicity, as UV 
radiation destroys any excess vitamin D 
that is produced.10
challenges to ImPlementatIon
z A matter of time
The primary challenge is likely to be 
the competing demands and limited re-
sources inherent in delivering all preven-
tive health services in the primary care 
setting. By one estimate, implementing 
all preventive health services recom-
mended by the US Preventive Services 
Task Force would require 7.4 hours per 
day, leaving little if any time to address 
the acute and chronic care needs of each 
individual patient.14 n
Purls methodology
This	 study	 was	 selected	 and	 evaluated	 using	 FPIN’s	
Priority	Updates	 from	 the	research	literature	Surveil-
lance	 System	 methodology.	 The	 criteria	 and	 findings	
leading	to	the	selection	of	this	study	as	a	PUrl	can	be	
accessed	at	www.jfponline.com/purls.
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